Literature DB >> 7929330

Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells.

N Arora1, L C Williamson, S H Leppla, J L Halpern.   

Abstract

The light chain of tetanus toxin is a zinc endoprotease that inhibits neurotransmitter release by selective proteolysis of the synaptic vesicle-associated protein synaptobrevin/vesicle-associated membrane protein. Cellubrevin is a homologue of synaptobrevin that is found in most cell types and is also a substrate for tetanus toxin. The lack of receptors for tetanus toxin on most cell types has made studies of tetanus toxin action in non-neuronal cells difficult. To characterize tetanus toxin effects in non-neuronal cells, a fusion protein consisting of the 254 amino-terminal amino acids of lethal factor (LF) of anthrax toxin and tetanus toxin light chain (LC) was prepared. This protein (LF-LC) inhibited evoked glycine release from primary spinal cord neurons at concentrations between 1.0 and 100 ng/ml. LF-LC was cytotoxic to RAW 264.7, ANA-1 cells (mouse macrophage cell lines), and Chinese hamster ovary cells in a dose-dependent manner. These effects required the presence of protective antigen, the receptor binding component of anthrax toxin. In contrast, LF-LC was not cytotoxic to RBL-2H3, Vero, or mouse hybridoma cell lines. Mutagenesis of conserved amino acids (His237 and Glu234) in the zinc-binding motif of LC resulted in fusion proteins having no biological activity. LF-LC did not inhibit regulated secretion of serotonin in RBL-2H3 cells or constitutive secretion in any non-neuronal cell lines as measured in several different assays. We suggest that the cytotoxic effects of LF-LC result from inhibition of a specific intracellular membrane fusion event mediated by cellubrevin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929330

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Normal and abnormal secretion by haemopoietic cells.

Authors:  J C Stinchcombe; G M Griffiths
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Protein engineering: security implications. The increasing ability to manipulate protein toxins for hostile purposes has prompted calls for regulation.

Authors:  Jonathan B Tucker; Craig Hooper
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

5.  Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo.

Authors:  J D Ballard; R J Collier; M N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Inhibition of degranulation and cytokine production in bone marrow-derived mast cells by hydrolyzed rice bran.

Authors:  Yuka Hoshino; Naohide Hirashima; Mamoru Nakanishi; Tadahide Furuno
Journal:  Inflamm Res       Date:  2010-03-05       Impact factor: 4.575

Review 7.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

8.  Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen.

Authors:  S R Blanke; J C Milne; E L Benson; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

9.  Site directed mutagenesis of histidine residues in anthrax toxin lethal factor binding domain reduces toxicity.

Authors:  N Arora
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

Review 10.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.